Skip to main content
Figure 1 | BMC Psychiatry

Figure 1

From: Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder

Figure 1

Kaplan-Meier plot: time to median clinical response from baseline in the short-term study by LDX treatment group (efficacy population, n=414). Log rank P-value: <.0001. P-value indicates overall significant effect among the treatment groups and was not specifically tested between any individual dose groups. Abbreviations: d=day; LDX=lisdexamfetamine dimesylate.

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us